For citations:
Goryainova AY, Stukan AI, Lymar EV, Khachmamuk ZK, Selezneva IG. Induction of ovarian steroidogenesis as an additional potential risk factor for progression in premenopausal patients with hormone-receptor-positive breast cancer receiving tamoxifen as adjuvant therapy. Meditsinskiy sovet = Medical Council. 2022;(9):131-138. (In Russ.) https://doi.org/10.21518/2079-701X-2022-16-9-131-138